Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Rising drug prices cost workers’ compensation programs
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Gilead ordered to pay $200m to Merck in patent row
Business By Rebecca Robbins Inside the $100 million ad blitz for a $1,100-a-pill drug for hepatitis C
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Glaxo searching for new CEO, Valeant CEO returns from illness
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Indian drug makers pursuing acquisitions, Mass. AG looking into Gilead
